%D8%A7%DB%8C%DA%A9%D8%A7%D8%AA%DB%8C%D8%A8%D8%A7%D9%86%D8%AAIcatibantIcatibantIcatibant%D8%A7%DB%8C%DA%A9%D8%A7%D8%AA%DB%8C%D8%A8%D8%A7%D9%86%D8%AAIcatibantIcatibantIcatibantIkatybantIcatibanto%D0%98%D0%BA%D0%B0%D1%82%D0%B8%D0%B1%D0%B0%D0%BD%D1%82IkatibantIkatibant%D0%86%D0%BA%D0%B0%D1%82%D1%96%D0%B1%D0%B0%D0%BD%D1%82Q902379
about
sameAs
P1056
P3781
Angiotensin-(1-7) administration reduces oxidative stress in diabetic bone marrow.Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity.The bradykinin B(2) receptor induces multiple cellular responses leading to the proliferation of human renal carcinoma cell lines.Renin-angiotensin system inhibitors and angioedema: anesthetic implications.Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States.Update on treatment of hereditary angioedema.Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study.Gangliosides stimulate bradykinin B2 receptors to promote calmodulin kinase II-mediated neuronal differentiation.Icatibant and ACE inhibitor angioedema.Discrepancies between guidelines and international practice in treatment of hereditary angioedema.Vasodilator and antihypertensive effects of a novel N-acylhydrazone derivative mediated by the inhibition of L-type Ca²⁺ channels.Successful perioperative management of a patient with C1 esterase inhibitor deficiency with a novel bradykinin receptor B2 antagonist.Safety and efficacy of icatibant self-administration for acute hereditary angioedema.Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation.[Hereditary angioedema. A therapeutic guide]Human tissue kallikrein 1 gene delivery inhibits PDGF-BB-induced vascular smooth muscle cells proliferation and upregulates the expressions of p27Kip1 and p2lCip1Inflammatory skin responses induced by icatibant injection are mast cell mediated and attenuated by H(1)-antihistaminesSwitch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report
P921
description
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Icatibant
@de
Icatibant
@es
Icatibant
@it
Icatibant
@nl
Icatibant
@vi
Ikatibant
@sh
Ikatibant
@sr
icatibant
@en
icatibant
@fr
icatibanto
@pt
type
label
Icatibant
@de
Icatibant
@es
Icatibant
@it
Icatibant
@nl
Icatibant
@vi
Ikatibant
@sh
Ikatibant
@sr
icatibant
@en
icatibant
@fr
icatibanto
@pt
altLabel
130308-48-4
@fr
C59H89N19O13S
@fr
C59H89N19O13S
@it
Firazyr
@de
HOE 140
@en
HOE-140
@en
prefLabel
Icatibant
@de
Icatibant
@es
Icatibant
@it
Icatibant
@nl
Icatibant
@vi
Ikatibant
@sh
Ikatibant
@sr
icatibant
@en
icatibant
@fr
icatibanto
@pt
P486
P592
P6366
P646
P661
P662
P683
P1579
P2017
C1CC[C@H]2[C@@H](C1)C[C@H](N2C ...... C(=O)N[C@@H](CCCN=C(N)N)C(=O)O
P2067
P2115
N0000183562
P2275
icatibant
@en